ETTLINGEN, Germany,
Feb. 22, 2018 /PRNewswire/ -- Bruker
today announced that it has acquired IRM2, a developer
of high-speed infrared (IR) imaging microscopes based on quantum
cascade laser (QCL) technology. Innovative, fast QCL
microscopy expands Bruker's technology portfolio and market
opportunities for infrared microscopy, with applications in
biological tissue analysis and materials science, and future
potential in tissue diagnostics. Financial details of the
transaction were not disclosed.
QCL is a novel technology in infrared and Raman microscopy, with
key customers at academic and government research institutions, as
well as in pharmaceutical and biotechnology companies. The
IRM2 QCL platform provides direct infrared imaging with
detector arrays at very high speed. A proprietary coherence
reduction technique delivers unprecedented image quality, so that
the composition of large sample areas can be studied much more
rapidly and at high lateral resolution.
Urban Fäh, President of Bruker Optics, stated: "Novel QCL
technology can offer major speed advantages for infrared and Raman
microscopy of large sampling areas, with great promise for the
selective screening of biological tissues. The QCL microscopy
technology expands our product portfolio, and we welcome the
addition of the talented IRM2 team, which provides
valuable new expertise."
Dr. Niels Kröger-Lui, founder and CEO of IRM2,
commented: "The IRM2 team is proud to become part of
Bruker. This is the next step in our vision of transferring
the results of our academic research to industrial products that
serve customers globally. We believe that Bruker provides the
environment for IRM2 to integrate our know-how and
technology into innovative and competitive QCL microscopy and
spectroscopy solutions."
About Bruker Corporation (NASDAQ: BRKR)
For more than
55 years, Bruker has enabled scientists to make breakthrough
discoveries and develop new applications that improve the quality
of human life. Bruker's high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, phenomics and
proteomics research, microbiology and molecular pathology research.
For more information, please visit: www.bruker.com.
Investor
Contact:
|
Media Contact for
Bruker Optics:
|
Miroslava
Minkova
|
Michael
Mueller
|
Head of Investor
Relations
|
Marketing
Manager
|
Bruker
Corporation
|
Bruker
Optics
|
T: +1 (978) 663-3660,
ext. 1479
|
T: +49 (7243)
504-2652
|
E:
miroslava.minkova@bruker.com
|
E:
michael.mueller@bruker.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/bruker-acquires-high-speed-qcl-infrared-microscopy-company-irm2-300602437.html
SOURCE Bruker Corporation